Find people 

Professor Anthony S David  FRCP, FRCPsych, MD, MSc
Professor of Cognitive Neuropsychiatry
Head of Section
Consultant Psychiatrist

emailcontact this person
tel0207 848 0138
fax020 7848 0572
address

Institute of Psychiatry
Box  P068
De Crespigny Park
London
United Kingdom, SE5 8AF

location m6.05
West Wing
departmentsPsychological Medicine
Psychosis Studies
alsoCognitive Neuropsychiatry

biography

Tony David graduated in medicine from Glasgow University in 1980 and trained in neurology before entering psychiatry. He also has a Masters degree in Cognitive Neuropsychology. He has been an honorary consultant at the Maudsley Hospital, London since 1990 and was awarded a personal chair form the Institute of Psychiatry and GKT School of Medicine in 1996.

Professor David has a wide and diverse range of research interests including schizophrenia, neuropsychiatry, medically unexplained syndromes and neuroimaging – both structural and functional. He is especially interested in the concept of insight in schizophrenia and how this relates to treatment compliance. Professor David is a Fellow of the Royal College of Physicians, the Royal College of Psychiatrists and the Academy of Medical Sciences. He is a member of the Experimental Psychology Society and a founder member of both the British Neuropsychological Society and British Neuropsychiatry Association and is an associate director of the Mental Health Research Network.

activities and interests

BRC Clinical Disorders Cluster lead

BRC Clinical Disorders Cluster lead

publications

Professor David is editor of the journal “Cognitive Neuropsychiatry” and has published five books including ’The Neuropsychology of Schizophrenia’ (1994) with J Cutting, ’Disorders of Brain and Mind’ (1998) with M Ron, ’The Self in Neuroscience and Psychiatry’ (2003) with T Kircher, ’Insight and Psychosis’ (2nd Ed) (2004) with X Amador and edited the new edition of ’Lishman’s Organic Psychiatry’. He is author of over 450 publications in peer reviewed medical and scientific journals.

Recent Publications:
Mack J, Okai D, Brown RG, Askey-Jones S, Chaudhuri KR, Martin A, Samuel M, David AS. The role of self-awareness and cognitive dysfunction in Parkinson’s disease with and without impulse control disorder. J Neuropsychiatr & Clin Neurosci. 25: 1-9.

Bedford N, Surguladze S, Giampietro V, Brammer MJ, David AS. (2012). Self-Evaluation in Schizophrenia: an fMRI Study with implications for the understanding of insight. BMC Psychiatry 12:106 doi:10.1186/1471-244X-12-106.

van der Meer L, de Vos AE, Stiekema APM, Pijnenborg GHM, van Tol M-J, Nolen WA, David AS, Aleman A. (in press). Insight in Schizophrenia: Involvement of Self-Reflection Networks? Schizophrenia Bull 2012; doi: 10.1093/schbul/sbs122

Naudts KH, Azevedo RT, David AS, van Heeringen K, Gibbs AA. (2012)Epistasis between 5­HTTLPR and ADRA2B polymorphisms in?uences attentional bias for emotional information in healthy volunteers. Int J Neuropsychopharmacology 15, 1027­1036.

Oliveira GNM, Kummer A, Marchetti RL, Filho GM, Salgado JV, David AS, Araújo Teixeira AL. (2012). A critical and descriptive approach to interictal behaviour with the Neurobehaviour Inventory (NBI). Epilepsy & Behaviour, 25: 334-40.

Di Forti M, Iyegbe C, Sallis H, Kolliakou A, Falcone A, Paparelli A, Siriani M, La Cascia C, Stilo SA, Marques TR, Handley R, Mondelli V, Dazzan P, Pariante P, David AS, Morgan C, Powell J, Murray RM. (2012). Confirmation that the AKT1 (rs 2494732) genotype influences the risk of psychosis in cannabis users. Biological Psychiatry. 72: 811–816.

Naudts KH, Azevedo RT, David AS, van Heeringen C, Gibb AA. (2012). Influence of COMT val158met and ADRA2B deletion polymorphisms on recollection and familiarity components of human emotional memory. J Psychopharmacology 26:819–829.

Brebion G, Ohlsen RI, Bressan RA, David AS. (2012). Source memory errors in schizophrenia, hallucinations and negative symptoms: a synthesis of research findings Psychological Medicine. 42, 2543-2554.

Aybek S, Nicholson TRJ, Draganski B, Daly E, Murphy DG, David AS, Kanaan RA. (in press) Grey matter changes in Motor Conversion disorder J Neurol Neurosurg Psychiat. 11 Dec 2012. doi:10.1136/jnnp-2012-304158

Pollak TA, Nicholson TR, Edwards MJ, David AS. A systematic review of transcranial magnetic stimulation in the treatment of functional (conversion) neurological symptoms. J Neurol Neurosurg Psychiatry published online Jan 8, 2013. doi: 10.1136/jnnp-2012-304181

Pijnenborg GHM, van Donkersgoed RJM, David AS, Aleman A. Changes in insight during treatment for psychotic disorders: A meta-analysis. Schiz Res. doi.org/10.1016/j.schres.2012.11.018

Wykes T, Rose D, Williams P, David AS. (2013).Working alliance and its relationship to outcomes in a randomized controlled trial (RCT) of antipsychotic medication. BMC Psychiatry, 13:28 doi:10.1186.

MacPhee GJA, Ray Chaudhuri K, David AS, Worth P, Wood B. (2013) Managing impulse control behaviours in Parkinson’s disease: practical guidelines. Brit J Hosp Med, 74: 160-5.

Wiffen BD, O’Connor JA, Geyer Anderson C, Marques TR, McQueen G, Happé F, Murray RM, David AS (2013).“I am sane but he is mad”: Insight and illness attributions to self and others in psychosis. Psychiatry Res. doi.org/10.1016/j.psychres. 2013.01.020.

Wiffen BD, O’Connor JA, Russo M, Falcone A, Joseph C, Kolliakou A, Di Forti M, Murray RM, David AS (2013). Do psychosis patients with poor insight show implicit awareness on the emotional Stroop task? Psychopathology. doi:10.1159/ 000350452.

Okai D, Askey-Jones S, Samuel M, Chaudhuri KR, Martin A, O’Sullivan SS, Chaudhuri KR, Martin A, Mack J, Brown RG, David AS. (2013) Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers. Neurology. 80:792-799.

Brown LB, Nicholson TR, Aybek S, Kanaan RA, David AS. (2013). Neuropsychological function and memory suppression in conversion disorder. Neuropsychology, doi:10.1111/jnp.12017

Zammit S, Kounali D, Cannon M, David AS, Gunnell D, Heron J, Jones PB, Lewis S, Sullivan S, Wolke D, Lewis G. Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiat, May 2013; doi: 10.1176/ appi.ajp.2013.12060768.

MacCabe JH, Wicks S, Lofving S, David AS, Berndtsson A, Gustafson J-E, Allebeck P, Dalman C. (2013) Decline in Cognitive Performance Between Ages 13 and 18 Years and the Risk for Psychosis in Adulthood. JAMA Psychiatry, 70: 261-70.

Bedford NJ, David AS. (2013) Denial of illness in schizophrenia as a disturbance of self-reflection, self-perception and insight. Schizophrenia Res. doi.org/10.1016/j.schres2013.07.006

Askey-Jones S, David AS, Silber E, Shaw P, Chalder T. (2013) Cognitive behavior therapy for common mental disorders in people with Multiple Sclerosis: a bench marking study. Behavioural Res and Therapy, 51: 648-55.

last updated: Thursday, September 05, 2013